The contribution of tumour-derived exosomes to the hallmarks of cancer

Katie L. Meehan, L.J J Vella

    Research output: Contribution to journalArticle

    35 Citations (Scopus)

    Abstract

    Exosomes are small, biologically active extracellular vesicles and over the last decade, both stromal and tumour-derived exosomes (TDE) have been implicated in cancer onset, progression and metastases. Cancer is a complex disease that is underpinned by several "cancer hallmarks", originally described by Hanahan and Weinberg in 2000 and then revised in 2011. The hallmarks of cancer comprise six biological capabilities, along with two emerging hallmarks and two enabling characteristics that facilitate tumour growth and metastatic dissemination. Ample evidence supports a clear role for TDE in four of the original biological hallmarks (sustaining proliferative signalling, resisting cell death, inducing angiogenesis and activating invasion and metastases). A less-defined role exists for TDE in evading growth suppressors, and currently, there is no evidence to suggest a role for TDE in enabling replicative immortality. TDE are intimately involved in the newly defined hallmarks of cancer and enabling characteristics, most evidently in immune inhibition and tumour-promoting inflammation, which ultimately enable escape from immune destruction and tumour progression. Herein, we discuss the role of TDE in the context of the hallmarks and enabling characteristics of cancer as defined by Hanahan and Weinberg. © 2015 Taylor and Francis.
    Original languageEnglish
    Pages (from-to)121-131
    Number of pages11
    JournalCritical Reviews in Clinical Laboratory Sciences
    Volume53
    Issue number2
    DOIs
    Publication statusPublished - 2016

    Fingerprint

    Exosomes
    Tumors
    Neoplasms
    Cell death
    Tumor Escape
    Neoplasm Metastasis
    Growth

    Cite this

    @article{384cb5715ce6467ab5aba895ad06fddd,
    title = "The contribution of tumour-derived exosomes to the hallmarks of cancer",
    abstract = "Exosomes are small, biologically active extracellular vesicles and over the last decade, both stromal and tumour-derived exosomes (TDE) have been implicated in cancer onset, progression and metastases. Cancer is a complex disease that is underpinned by several {"}cancer hallmarks{"}, originally described by Hanahan and Weinberg in 2000 and then revised in 2011. The hallmarks of cancer comprise six biological capabilities, along with two emerging hallmarks and two enabling characteristics that facilitate tumour growth and metastatic dissemination. Ample evidence supports a clear role for TDE in four of the original biological hallmarks (sustaining proliferative signalling, resisting cell death, inducing angiogenesis and activating invasion and metastases). A less-defined role exists for TDE in evading growth suppressors, and currently, there is no evidence to suggest a role for TDE in enabling replicative immortality. TDE are intimately involved in the newly defined hallmarks of cancer and enabling characteristics, most evidently in immune inhibition and tumour-promoting inflammation, which ultimately enable escape from immune destruction and tumour progression. Herein, we discuss the role of TDE in the context of the hallmarks and enabling characteristics of cancer as defined by Hanahan and Weinberg. {\circledC} 2015 Taylor and Francis.",
    author = "Meehan, {Katie L.} and Vella, {L.J J}",
    year = "2016",
    doi = "10.3109/10408363.2015.1092496",
    language = "English",
    volume = "53",
    pages = "121--131",
    journal = "Critical Reviews in Clinical Laboratory Sciences",
    issn = "1040-8363",
    publisher = "Informa Healthcare USA",
    number = "2",

    }

    The contribution of tumour-derived exosomes to the hallmarks of cancer. / Meehan, Katie L.; Vella, L.J J.

    In: Critical Reviews in Clinical Laboratory Sciences, Vol. 53, No. 2, 2016, p. 121-131.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - The contribution of tumour-derived exosomes to the hallmarks of cancer

    AU - Meehan, Katie L.

    AU - Vella, L.J J

    PY - 2016

    Y1 - 2016

    N2 - Exosomes are small, biologically active extracellular vesicles and over the last decade, both stromal and tumour-derived exosomes (TDE) have been implicated in cancer onset, progression and metastases. Cancer is a complex disease that is underpinned by several "cancer hallmarks", originally described by Hanahan and Weinberg in 2000 and then revised in 2011. The hallmarks of cancer comprise six biological capabilities, along with two emerging hallmarks and two enabling characteristics that facilitate tumour growth and metastatic dissemination. Ample evidence supports a clear role for TDE in four of the original biological hallmarks (sustaining proliferative signalling, resisting cell death, inducing angiogenesis and activating invasion and metastases). A less-defined role exists for TDE in evading growth suppressors, and currently, there is no evidence to suggest a role for TDE in enabling replicative immortality. TDE are intimately involved in the newly defined hallmarks of cancer and enabling characteristics, most evidently in immune inhibition and tumour-promoting inflammation, which ultimately enable escape from immune destruction and tumour progression. Herein, we discuss the role of TDE in the context of the hallmarks and enabling characteristics of cancer as defined by Hanahan and Weinberg. © 2015 Taylor and Francis.

    AB - Exosomes are small, biologically active extracellular vesicles and over the last decade, both stromal and tumour-derived exosomes (TDE) have been implicated in cancer onset, progression and metastases. Cancer is a complex disease that is underpinned by several "cancer hallmarks", originally described by Hanahan and Weinberg in 2000 and then revised in 2011. The hallmarks of cancer comprise six biological capabilities, along with two emerging hallmarks and two enabling characteristics that facilitate tumour growth and metastatic dissemination. Ample evidence supports a clear role for TDE in four of the original biological hallmarks (sustaining proliferative signalling, resisting cell death, inducing angiogenesis and activating invasion and metastases). A less-defined role exists for TDE in evading growth suppressors, and currently, there is no evidence to suggest a role for TDE in enabling replicative immortality. TDE are intimately involved in the newly defined hallmarks of cancer and enabling characteristics, most evidently in immune inhibition and tumour-promoting inflammation, which ultimately enable escape from immune destruction and tumour progression. Herein, we discuss the role of TDE in the context of the hallmarks and enabling characteristics of cancer as defined by Hanahan and Weinberg. © 2015 Taylor and Francis.

    U2 - 10.3109/10408363.2015.1092496

    DO - 10.3109/10408363.2015.1092496

    M3 - Article

    VL - 53

    SP - 121

    EP - 131

    JO - Critical Reviews in Clinical Laboratory Sciences

    JF - Critical Reviews in Clinical Laboratory Sciences

    SN - 1040-8363

    IS - 2

    ER -